CV Advisors’s AbbVie ABBV Stock Holding History

CV Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$942K	Hold	3,600	–	–	0.16%	56
2026 Q2	$906K	Buy	+3,600	New	+$775K	0.17%	62

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

CV Advisors's ABBV Position: Q3 2026 in Review

CV Advisors held its AbbVie (ABBV) position steady in Q3 2026 at 3,600 shares worth $942K. The position accounts for 0.16% of the portfolio, ranked #56.

CV Advisors first reported a position in ABBV in Q2 2026 and has held it in 2 quarters since. 1,234 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

CV Advisors held 3,600 shares of AbbVie worth $942K as of Q3 2026.
CV Advisors left its AbbVie share count unchanged in Q3 2026.
AbbVie made up 0.16% of CV Advisors's portfolio in Q3 2026, its #56 holding.
CV Advisors first reported a position in AbbVie in Q2 2026 and has held it in 2 quarters since.
1,234 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on CV Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.